MATRIFEN

This brand name is authorized in Austria, Cyprus, Estonia, Finland, France, Germany, Ireland, Lithuania, Malta, Poland, Spain, UK.

Active ingredients

The drug MATRIFEN contains one active pharmaceutical ingredient (API):

1
UNII UF599785JZ - FENTANYL
 

Fentanyl is a potent µ-opioid analgesic with rapid onset of analgesia and short duration of action. Its primary therapeutic actions are analgesia and sedation and is approximately 100-fold more potent than morphine as an analgesic. Secondary effects of fentanyl on central nervous system (CNS), respiratory and gastro-intestinal function are typical of opioid analgesics and are considered to be class effects.

 
Read more about Fentanyl

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 MATRIFEN Transdermal patch MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
N01AH01 Fentanyl N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AH Opioid anesthetics
Discover more medicines within N01AH01
N02AB03 Fentanyl N Nervous system → N02 Analgesics → N02A Opioids → N02AB Phenylpiperidine derivatives
Discover more medicines within N02AB03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
DE Bundesinstitut für Arzneimittel und Medizinprodukte 07330574, 07330806, 07330829, 07330835, 07330870, 07330901, 07331042, 07331059, 07331125, 07331131, 10122046, 10122052, 10122069, 10122075, 10122081, 10122098, 10122106, 10122112, 10122129, 10122135, 10122141, 10122158, 10122164, 10122170, 10122187, 10122193, 10122201, 10122218, 10122224, 10122230, 10122247, 10122253, 10122276, 10122282, 10122299, 10122307, 10122313, 10122336, 10122342, 10122359, 11148711, 11148912, 11148929, 11690930, 11690947, 11690953, 11690976, 11690982, 11690999
EE Ravimiamet 1223121, 1223132, 1223143, 1223154, 1223165, 1227013, 1227035, 1227057, 1227068, 1227079, 1227080, 1227103, 1227114, 1227125, 1227181, 1227204, 1227215, 1227226, 1227237, 1227259, 1227260, 1227271, 1227338, 1227350, 1227361, 1268344, 1268355, 1268366, 1268377, 1268388, 1268399, 1268401, 1268412, 1268423, 1268434, 1268445, 1268456, 1268467, 1268489, 1268490, 1268502, 1268513, 1268524, 1268535, 1268546
ES Centro de información online de medicamentos de la AEMPS 68363, 68364, 68365, 68366, 68367
FI Lääkealan turvallisuus- ja kehittämiskeskus 055642, 055687, 055733, 055778, 055824
FR Base de données publique des médicaments 60356727, 61270455, 66537773, 67439271, 69419292
GB Medicines & Healthcare Products Regulatory Agency 110848, 110850, 110854, 110858, 110860, 373820, 373846, 373853, 373857, 373859, 376744, 376748, 380993, 380995, 380997
IE Health Products Regulatory Authority 57240, 57245, 57252, 57279, 57283
LT Valstybinė vaistų kontrolės tarnyba 1004610, 1004611, 1004612, 1004613, 1004614, 1022292, 1022293, 1022294, 1022295, 1022296, 1023453, 1023454, 1023455, 1023459, 1023460, 1023461, 1023462, 1023463, 1023464, 1023465, 1023466, 1023467, 1023468, 1023469, 1023470, 1023832, 1023833, 1023834, 1023835, 1023836, 1023837, 1023838, 1023839, 1023840, 1023841, 1023842, 1023843, 1023844, 1023845, 1023846, 1023847, 1023848, 1023849, 1023850, 1023851
MT Medicines Authority AA565/76101, AA565/76102
PL Rejestru Produktów Leczniczych 100146249, 100147591, 100152103, 100174984, 100174990, 100458336

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.